The 2017 economic burden of diagnosed diabetes in the U.S. was estimated at $327 billion, including $237 billion in direct medical costs and $90 billion in lost productivity. Diabetes accounts for 1 in 4 U.S. health care dollars, with over half of that expenditure directly linked to diabetes. People with diabetes incur an average of $16,750 in annual medical costs, of which $9,600 is attributed to diabetes. Medical costs for people with diabetes are 2.3 times higher than what they would be without diabetes. Indirect costs include $3.3 billion in absenteeism, $26.9 billion in reduced productivity while working, $2.3 billion in reduced productivity for those not in the labor force, $37.5 billion in inability to work due to disability, and $19.9 billion in lost productivity from 277,000 premature deaths. After adjusting for inflation, diabetes costs increased by 26% from 2012 to 2017 due to increased prevalence and costs per person. The growth in diabetes prevalence and medical costs is primarily among those aged 65 and older, contributing to rising costs for Medicare. The study highlights the substantial financial burden of diabetes on society, including intangible costs like pain and suffering, and the costs of nonpaid caregiving. The report was prepared by the American Diabetes Association and includes data from various national surveys and databases. The study used a prevalence-based approach to estimate the economic burden of diabetes in 2017, considering factors such as age, sex, race/ethnicity, insurance coverage, and medical conditions. The findings show that diabetes-related costs have increased significantly, with a 25% rise in total economic burden from 2012 to 2017. The study also notes that the costs of diabetes-related care are higher for older adults and that the burden is growing due to increased prevalence and medical costs. The study highlights the need for strategies to reduce diabetes prevalence and its associated economic burden.The 2017 economic burden of diagnosed diabetes in the U.S. was estimated at $327 billion, including $237 billion in direct medical costs and $90 billion in lost productivity. Diabetes accounts for 1 in 4 U.S. health care dollars, with over half of that expenditure directly linked to diabetes. People with diabetes incur an average of $16,750 in annual medical costs, of which $9,600 is attributed to diabetes. Medical costs for people with diabetes are 2.3 times higher than what they would be without diabetes. Indirect costs include $3.3 billion in absenteeism, $26.9 billion in reduced productivity while working, $2.3 billion in reduced productivity for those not in the labor force, $37.5 billion in inability to work due to disability, and $19.9 billion in lost productivity from 277,000 premature deaths. After adjusting for inflation, diabetes costs increased by 26% from 2012 to 2017 due to increased prevalence and costs per person. The growth in diabetes prevalence and medical costs is primarily among those aged 65 and older, contributing to rising costs for Medicare. The study highlights the substantial financial burden of diabetes on society, including intangible costs like pain and suffering, and the costs of nonpaid caregiving. The report was prepared by the American Diabetes Association and includes data from various national surveys and databases. The study used a prevalence-based approach to estimate the economic burden of diabetes in 2017, considering factors such as age, sex, race/ethnicity, insurance coverage, and medical conditions. The findings show that diabetes-related costs have increased significantly, with a 25% rise in total economic burden from 2012 to 2017. The study also notes that the costs of diabetes-related care are higher for older adults and that the burden is growing due to increased prevalence and medical costs. The study highlights the need for strategies to reduce diabetes prevalence and its associated economic burden.